Follow
Focke Ziemssen
Focke Ziemssen
UKT
Verified email at med.uni-tuebingen.de
Title
Cited by
Cited by
Year
Penetration of bevacizumab through the retina after intravitreal injection in the monkey
P Heiduschka, H Fietz, S Hofmeister, S Schultheiss, AF Mack, S Peters, ...
Investigative ophthalmology & visual science 48 (6), 2814-2823, 2007
3392007
A swarm of slippery micropropellers penetrates the vitreous body of the eye
Z Wu, J Troll, HH Jeong, Q Wei, M Stang, F Ziemssen, Z Wang, M Dong, ...
Science advances 4 (11), eaat4388, 2018
3042018
Intracameral bevacizumab for iris rubeosis
S Grisanti, S Biester, S Peters, O Tatar, F Ziemssen, KU Bartz-Schmidt, ...
American journal of ophthalmology 142 (1), 158-160, 2006
2592006
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
S Peters, P Heiduschka, S Julien, F Ziemssen, H Fietz, KU Bartz-Schmidt, ...
American journal of ophthalmology 143 (6), 995-1002. e2, 2007
2512007
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ...
The Lancet Neurology 16 (3), 189-199, 2017
2162017
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn
E Yoeruek, F Ziemssen, S Henke‐Fahle, O Tatar, A Tura, S Grisanti, ...
Acta Ophthalmologica 86 (3), 322-328, 2008
1882008
Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
Q Zhu, F Ziemssen, S Henke-Fahle, O Tatar, P Szurman, S Aisenbrey, ...
Ophthalmology 115 (10), 1750-1755. e1, 2008
1832008
Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration
S Aisenbrey, F Ziemssen, M Völker, F Gelisken, P Szurman, G Jaissle, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 245 (7), 941-948, 2006
1392006
One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion
GB Jaissle, M Leitritz, F Gelisken, F Ziemssen, KU Bartz-Schmidt, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 247 (1), 27-33, 2009
1372009
Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema
MS Spitzer, F Ziemssen, E Yoeruek, K Petermeier, S Aisenbrey, ...
Journal of Cataract & Refractive Surgery 34 (1), 70-75, 2008
1352008
Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study
S Grisanti, P Szurman, M Warga, R Kaczmarek, F Ziemssen, O Tatar, ...
Investigative ophthalmology & visual science 46 (1), 191-196, 2005
1232005
The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)
T Ziemssen, F Ziemssen
Autoimmunity reviews 4 (7), 460-467, 2005
1172005
Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use
PJ Patel, F Ziemssen, E Ng, A Muthutantri, D Silverman, EA Tschosik, ...
Clinical Ophthalmology (Auckland, NZ) 14, 15, 2020
1012020
Bevacizumab for treatment of macular edema secondary to retinal vein occlusion
GB Jaissle, F Ziemssen, K Petermeier, P Szurman, M Ladewig, F Gelisken, ...
Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft …, 2006
1012006
A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation
M Vorgerd, K Ricker, F Ziemssen, W Kress, HH Goebel, WA Nix, ...
Neurology 57 (12), 2273-2277, 2001
942001
Bevacizumab: off-label use in ophthalmology
S Grisanti, F Ziemssen
Indian journal of ophthalmology 55 (6), 417, 2007
882007
Effects of bevacizumab on retinal function in isolated vertebrate retina
M Lüke, M Warga, F Ziemssen, F Gelisken, S Grisanti, T Schneider, ...
British journal of ophthalmology 90 (9), 1178-1182, 2006
862006
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization
AM Mansour, JF Arevalo, F Ziemssen, A Mehio-Sibai, F Mackensen, ...
American journal of ophthalmology 148 (2), 310-316. e2, 2009
832009
Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability
S Peters, IA Cree, R Alexander, P Turowski, Z Ockrim, J Patel, SR Boyd, ...
Cytokine 40 (2), 144-150, 2007
772007
Intravitreal bevacizumab in inflammatory ocular neovascularization
AM Mansour, F Mackensen, JF Arevalo, F Ziemssen, P Mahendradas, ...
American journal of ophthalmology 146 (3), 410-416. e1, 2008
752008
The system can't perform the operation now. Try again later.
Articles 1–20